SANTA
CLARA, Calif., Aug. 26,
2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq:
SMLR), a pioneer in developing and marketing technology products
and services to healthcare providers to combat chronic diseases,
today announced that it has purchased an additional 83 bitcoins for
$5.0 million in cash, inclusive of
fees and expenses. As of August 26,
2024, Semler Scientific holds a total of 1,012 bitcoins,
which were acquired for $68.0
million, inclusive of fees and expenses.
"We recently purchased additional bitcoins using primarily cash
from operations as well as capital raised through our at-the-market
equity program," said Eric Semler,
chairman of Semler Scientific. "We are encouraged by the growing
institutional adoption of bitcoin. It was recently
reported that for the first time, institutions own more than 20% of
bitcoin ETF assets under management. We believe this
increasing institutionalization will drive value for both
bitcoin prices and for our stockholders."
About Semler Scientific, Inc.:
Semler Scientific, Inc. develops, manufactures and markets
innovative products and services to combat chronic diseases. Its
flagship product, QuantaFlo®, which is patented and cleared by the
U.S. Food and Drug Administration (FDA), is a rapid point-of-care
test that measures arterial blood flow in the extremities. The
QuantaFlo test aids in the diagnosis of cardiovascular diseases,
such as peripheral arterial disease (PAD), and Semler Scientific is
seeking a new 510(k) clearance for expanded-indications. QuantaFlo
is used by healthcare providers to evaluate their patient's risk of
mortality and major adverse cardiovascular events (MACE). Semler
Scientific also invests in bitcoin and has adopted
bitcoin as its primary treasury asset. Additional
information about Semler Scientific can be found at
www.semlerscientific.com.
Forward-Looking Statements
This press release contains "forward-looking" statements. Such
statements can be identified by, among other things, the use of
forward-looking language such as the words "believe," "goal,"
"may," "will," "intend," "expect," "anticipate," "estimate,"
"project," "would," "could" or words with similar meaning or the
negatives of these terms or by the discussion of strategy or
intentions. The forward-looking statements in this release include
express or implied statements regarding the increasing
institutionalization of bitcoin; bitcoin
prices; effects of same for its stockholders; and expanding
indications for QuantaFlo; among others. Such forward-looking
statements are subject to a number of risks and uncertainties that
could cause Semler Scientific's actual results to differ materially
from those discussed here, such as risks inherent with investing in
bitcoin, including bitcoin's volatility;
risk of implementing a new bitcoin treasury strategy;
and risks of obtaining an additional 510(k) clearance; along with
those other risk factors detailed in Semler Scientific's filings
with the Securities and Exchange Commission. These forward-looking
statements involve assumptions, estimates, and uncertainties that
reflect current internal projections, expectations or beliefs.
There can be no assurance that such statements will prove to be
accurate, and actual results and future events could differ
materially from those anticipated in such statements. All
forward-looking statements contained in this press release are
qualified in their entirety by these cautionary statements and the
risk factors described above. Furthermore, all such statements are
made as of the date of this release and Semler Scientific assumes
no obligation to update or revise these statements unless otherwise
required by law.
CONTACT:
Renae Cormier, CFO
ir@semlerscientific.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/semler-scientific-announces-additional-bitcoin-purchases-302230158.html
SOURCE Semler Scientific, Inc.